15. Are More Doses Better?

So far, the clinical trial evaluated only one or two doses of lepodisiran. It remains unclear if more frequent or prolonged dosing could offer even greater or more durable Lp(a) reduction. Future research will focus on finding the optimal dosing schedule for sustained benefit.